Hemo Organic EGM Notice: Capital Increase and ₹12.47 Crore Warrant Issue Approved
Hemo Organic Limited has issued an official EGM notice for January 7, 2026, seeking shareholder approval for authorized capital increase from ₹10 crores to ₹13.45 crores and issuance of 99.75 lakh convertible warrants worth ₹12.47 crores to non-promoter investors. The funds will be utilized 75% for working capital and 25% for general corporate purposes.
*this image is generated using AI for illustrative purposes only.
Hemo Organic Limited has issued an official notice for its Extra-Ordinary General Meeting (EGM) scheduled for January 7, 2026, at 4:00 PM through video conferencing. The meeting will seek shareholder approval for increasing authorized share capital and issuing convertible warrants worth ₹12.47 crores to non-promoter investors.
EGM Details and Voting Process
The company has set December 31, 2025, as the cut-off date for determining eligible shareholders for voting rights. Remote e-voting will be available from January 4, 2026, at 9:00 AM to January 6, 2026, at 5:00 PM through NSDL's e-voting platform.
| EGM Parameters: | Details |
|---|---|
| Meeting Date: | January 7, 2026 |
| Meeting Time: | 4:00 PM (IST) |
| Mode: | Video Conferencing (VC/OAVM) |
| Cut-off Date: | December 31, 2025 |
| E-voting Period: | January 4-6, 2026 |
Authorized Capital Increase Resolution
Shareholders will vote on increasing the company's authorized share capital through an ordinary resolution. The proposal aims to accommodate future business requirements and growth prospects.
| Capital Structure: | Current | Proposed |
|---|---|---|
| Authorized Capital: | ₹10.00 crores | ₹13.45 crores |
| Number of Shares: | 1.00 crore | 1.35 crore |
| Face Value: | ₹10.00 per share | ₹10.00 per share |
The increase will enable the company to issue new shares ranking pari passu with existing equity shares, with corresponding alterations to the Memorandum of Association.
Convertible Warrant Issue Details
The second agenda involves a special resolution for issuing 99.75 lakh convertible warrants to non-promoter category investors. The warrants carry an 18-month conversion period from the allotment date.
| Warrant Issue Specifications: | Details |
|---|---|
| Total Warrants: | 99.75 lakh |
| Issue Price: | ₹12.50 per warrant |
| Face Value: | ₹10.00 per warrant |
| Premium: | ₹2.50 per warrant |
| Total Amount: | ₹12.47 crores |
| Conversion Period: | 18 months |
| Relevant Date: | December 8, 2025 |
Proposed Allottee Distribution
The warrants will be allocated among three non-promoter investors, with Managing Director Vishwambar Kameshwar Singh being the largest individual allottee.
| Investor Name: | Warrants (Lakh) | Post-Conversion Holding (%) |
|---|---|---|
| Vishwambar Kameshwar Singh: | 33.00 | 24.60% |
| Vacro Enterprises Private Limited: | 33.50 | 24.92% |
| Qmin Realities Private Limited: | 33.25 | 24.74% |
| Total: | 99.75 | 74.26% |
Pricing and Fund Utilization
The issue price of ₹12.50 per warrant has been determined based on SEBI ICDR regulations, considering the higher of 90-day and 10-day volume-weighted average prices. The floor price computed under SEBI regulations stands at ₹12.45 per share.
| Fund Utilization: | Amount (₹ Crores) | Percentage |
|---|---|---|
| Working Capital Requirements: | 9.35 | 75.00% |
| General Corporate Purposes: | 3.12 | 25.00% |
| Total Issue Proceeds: | 12.47 | 100.00% |
A valuation report from Procurve Valux Private Limited, a registered valuer entity, supports the pricing determination. The report dated December 11, 2025, is available for inspection at the company's registered office and website.
Regulatory Compliance and Lock-in
Warrant holders must pay 25% of the issue price upfront, with the remaining 75% payable during conversion to equity shares. The resulting equity shares will be subject to lock-in provisions as per SEBI ICDR regulations, with additional lock-in periods as mutually agreed between the company and allottees.
The company has appointed Jay Pandya & Associates as the scrutinizer for the e-voting process, ensuring fair and transparent conduct of the meeting. The allotment will be completed within 15 days of the special resolution passage, subject to regulatory approvals.
Historical Stock Returns for Hemo Organic
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -1.95% | -8.86% | +62.11% | +70.89% | +44.82% | +24.90% |
20
